Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01356225Phase 2Completed
Phase 2, randomised, double-blind trial in postoperative pain comparing Intranasal Ketorolac with Intranasal Placebo (2 arms). Primary endpoint: Summed Pain Intensity Difference at 8 hours. Started Feb 2004; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01356225.